What is she best known for?
The fields of study she is best known for:
- Gene
- Apoptosis
- Internal medicine
Cell biology, Myocyte, Basic fibroblast growth factor, Fibroblast growth factor and Internal medicine are her primary areas of study.
The study incorporates disciplines such as Molecular biology, Growth factor, DNA synthesis and Skeletal muscle in addition to Cell biology.
Her research investigates the connection with Basic fibroblast growth factor and areas like Stimulation which intersect with concerns in Transforming growth factor, In vitro, Endogeny, Messenger RNA and Mitogen-activated protein kinase.
Her Fibroblast growth factor research incorporates elements of Signal transduction, Connective tissue, Paracrine signalling and Intercalated disc.
Her work on Cardioprotection as part of general Internal medicine study is frequently linked to Vasculogenesis, bridging the gap between disciplines.
Her Connexin research focuses on Phosphorylation and how it relates to Programmed cell death.
Her most cited work include:
- The carboxy-tail of connexin-43 localizes to the nucleus and inhibits cell growth (189 citations)
- Cardiac fibroblast to myofibroblast differentiation in vivo and in vitro: Expression of focal adhesion components in neonatal and adult rat ventricular myofibroblasts (183 citations)
- Biological activities of fibroblast growth factor-2 in the adult myocardium. (168 citations)
What are the main themes of her work throughout her whole career to date?
Elissavet Kardami mainly investigates Cell biology, Internal medicine, Fibroblast growth factor, Endocrinology and Myocyte.
Her Cell biology research integrates issues from Chromatin and Biochemistry, Cell growth.
Her Internal medicine research is multidisciplinary, incorporating perspectives in Signal transduction and Cardiology.
Her study explores the link between Fibroblast growth factor and topics such as Fibroblast that cross with problems in Immunology.
Her Myocyte research is multidisciplinary, relying on both Cardiac muscle, Basic fibroblast growth factor, Molecular biology, Skeletal muscle and Myosin.
Elissavet Kardami focuses mostly in the field of Cardioprotection, narrowing it down to topics relating to Protein kinase C and, in certain cases, Programmed cell death.
She most often published in these fields:
- Cell biology (43.62%)
- Internal medicine (34.23%)
- Fibroblast growth factor (34.90%)
What were the highlights of her more recent work (between 2011-2021)?
- Cell biology (43.62%)
- Programmed cell death (12.08%)
- Doxorubicin (6.04%)
In recent papers she was focusing on the following fields of study:
Her primary scientific interests are in Cell biology, Programmed cell death, Doxorubicin, Internal medicine and Cancer research.
Elissavet Kardami regularly ties together related areas like Cell growth in her Cell biology studies.
Elissavet Kardami combines subjects such as Mitochondrion, Protein kinase C and Pharmacology with her study of Programmed cell death.
As part of her studies on Internal medicine, Elissavet Kardami often connects relevant areas like Endocrinology.
The Endocrinology study combines topics in areas such as Fibrosis, Fibronectin, Angiogenesis and Fibroblast growth factor.
The various areas that Elissavet Kardami examines in her Phosphorylation study include Cardioprotection and Gap junction.
Between 2011 and 2021, her most popular works were:
- Autophagy and mitophagy in the context of doxorubicin-induced cardiotoxicity (93 citations)
- The FGF-2-triggered protection of cardiac subsarcolemmal mitochondria from calcium overload is mitochondrial connexin 43-dependent (44 citations)
- The FGF-2-triggered protection of cardiac subsarcolemmal mitochondria from calcium overload is mitochondrial connexin 43-dependent (44 citations)
In her most recent research, the most cited papers focused on:
- Gene
- Apoptosis
- Internal medicine
Her main research concerns Programmed cell death, Cell biology, Cardioprotection, Phosphorylation and Connexin.
Her Programmed cell death study combines topics from a wide range of disciplines, such as Cell, Cancer research, Cardiotoxicity, Doxorubicin and Mitochondrion.
Her biological study spans a wide range of topics, including Fibronectin, Fibroblast growth factor, Receptor, Angiotensin II and Fibrosis.
The Phosphorylation study combines topics in areas such as Adipogenesis and Gap junction.
Her Gap junction study combines topics from a wide range of disciplines, such as Cytoprotection, Myocyte, Signal transduction and Cell growth.
Her work carried out in the field of Connexin brings together such families of science as Cardiomyopathy, Endoplasmic reticulum and Immunology.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
